$CRNT

Ceragon Networks (CRNT) Is Banking on India to Make Up for a Slow Start to 2026

Ceragon Networks (NASDAQ:CRNT) reported Q1 2026 revenue of $85.0 million, down 4.1% year over year but above Wall Street’s $80.4 million consensus, according to the company. CEO Doron Arazi attributed the decline to timing of Indian operator orders converting to revenue. India accounted for 35% of revenue; management said it booked about $86 million in orders year-to-date, with ~$24 million recognized in Q1. Non-GAAP EPS was $0.01 vs $0.03 in Q1 2025; GAAP gross margin rose to 35.4%. CFO Ronen S

Original reporting
Published Jun 1, 2026, 9:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 1, 2026, 10:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Ceragon Networks (CRNT) Is Banking on India to Make Up for a Slow Start to 2026 — source image
Decision brief

The 30-second read

$CRNTBullishMed
01

Why it matters

The key trading variable is whether the remaining Indian order backlog converts into revenue by year-end as management expects, supporting the reiterated full-year range.

02

Market read

Earnings beat plus reiterated guidance and a quantified India order-to-revenue catch-up narrative can influence positioning in optical networking names.

03

What to watch

Only two Indian telecom providers are cited as the concentration source; any customer-specific delays could disproportionately impact Ceragon’s revenue cadence.

Relevance 9/10Novelty 7/10Timing: After-hours/earnings follow-through from the May 19 Q1 2026 print

Background

Ceragon’s Q1 2026 revenue declined YoY but beat consensus, attributed to late conversion of large Indian operator orders into recognized revenue.

Company-level read

Ticker impact

$CRNTBullishMedium confidence
Context

Ceragon reported Q1 2026 results and reiterated full-year 2026 outlook, with India-driven revenue timing and catch-up plan details.

Expected impact

Moderate positive bias as guidance is reiterated and India revenue mix/catch-up reduces near-term execution risk, though EPS decline may cap upside.

Evidence & confidence

The article provides concrete Q1 datapoints (revenue, margins, EPS) plus reiterated full-year targets and a specific explanation for the timing issue and expected revenue catch-up by year-end.

Market effects

Signals demand normalization/conversion dynamics in optical transport/backhaul, with India operator order timing influencing near-term revenue recognition.

Highlights India as a key swing factor (35% of revenue) and suggests revenue visibility improves as orders convert through year-end.

Reinforces that regional telecom capex/order conversion timing can materially affect optical networking revenue trajectories globally.

Counterpoint

The revenue beat may be largely timing-driven; if Indian operator conversion slips again, year-end catch-up could compress margins or revenue.

Key entities

  • Ceragon Networks Ltd.

    Optical networking provider reporting Q1 2026 results and reiterating full-year 2026 outlook with India-driven revenue timing.

  • Doron Arazi

    CEO who attributed YoY revenue dip to timing and described the India catch-up plan.

  • Ronen Stein

    CFO who reiterated full-year 2026 revenue and margin outlook.

Related articles

$CRNTLow

Craig - Hallum Raises its Price Target on Ceragon Networks (CRNT)

On May 20, 2026, Craig-Hallum analyst Christian Schwab raised Ceragon Networks’ (CRNT) price target to $4 from $3 and kept a Buy rating, citing solid Q1 results and full-year revenue guidance of $355M–$385M. Roth Capital analyst Scott Searle raised its target to $4.50 from $3.75, also maintaining Buy. Ceragon reported Q1 non-GAAP EPS of 1c and revenue of $85.0M, above consensus, while noting margin pressure from costs and FX.

$MMIMed

Marcus & Millichap Q2 Earnings Call Highlights

Marcus & Millichap (NYSE: MMI) reported Q2 financing revenue up 15% to $30 million, with transaction count up 17% to 480 and financing dollar volume up 5% to $4 billion. For the first half, financing revenue rose 29% to $57 million. Operating expenses rose to $201 million. Cash equivalents and marketable securities were $345 million. The board declared a $0.25 semiannual dividend and authorized further share repurchases.

$MOSMed

Mosaic Q2 Earnings Call Highlights

Mosaic (NYSE:MOS) said Q2 U.S. phosphate application was nearly 15% below normal and could drop another 20% in 2027. In Brazil, it expects phosphate nutrient application to fall about 30% in 2024 after normal levels in 2023, citing yield pressure. Mosaic guided Q3 sulfur costs $700-$710/ton, ammonia $610-$620, DAP FOB $820-$840, and Q3 phosphate sales 1.1-1.4M tons.